Markin Rodney S 4
4 · Cardiff Oncology, Inc. · Filed Mar 29, 2021
Insider Transaction Report
Form 4
Markin Rodney S
Director
Transactions
- Purchase
Common Stock
2021-03-26$10.32/sh+2,900$29,933→ 23,879 total(indirect: Fund)
Holdings
- 7,181
Common Stock
Footnotes (1)
- [F1]Through Prairie Ventures, LLC